104 related articles for article (PubMed ID: 6601015)
1. B lymphocyte activation: entry into cell cycle is accompanied by decreased expression of IgD but not IgM.
Monroe JG; Havran WL; Cambier JC
Eur J Immunol; 1983 Mar; 13(3):208-13. PubMed ID: 6601015
[TBL] [Abstract][Full Text] [Related]
2. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population.
Finkelman FD; Mond JJ; Metcalf ES
J Immunol; 1983 Aug; 131(2):593-600. PubMed ID: 6602840
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of surface IgD fails to protect from tolerance-induction. Both surface IgM- and surface IgD-mediated signals induce apoptosis of immature murine B lymphocytes.
Norvell A; Monroe JG
J Immunol; 1996 Feb; 156(4):1328-32. PubMed ID: 8568230
[TBL] [Abstract][Full Text] [Related]
4. Surface immunoglobulin phenotype of complement receptor-positive and complement receptor-negative B cells of normal and xid immunodeficient mice.
Lindsten T; Finkelman FD; Thompson CB; Andersson B; Scher I
Eur J Immunol; 1984 Apr; 14(4):329-35. PubMed ID: 6609823
[TBL] [Abstract][Full Text] [Related]
5. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
Mathur A; Lynch RG; Köhler G
J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
[TBL] [Abstract][Full Text] [Related]
6. Maturation of B lymphocytes. II. Sequential appearance of increasing IgM and IgD in the adult bone marrow.
Lala PK; Layton JE; Nossal GJ
Eur J Immunol; 1979 Jan; 9(1):39-44. PubMed ID: 374092
[TBL] [Abstract][Full Text] [Related]
7. sIgD-negative B cells from neonatal mice do not respond to the thymus-independent antigen TNP-BA in limiting dilution cultures.
McFadden SF; Vitetta ES
J Immunol; 1984 Apr; 132(4):1717-21. PubMed ID: 6607945
[TBL] [Abstract][Full Text] [Related]
8. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
Cambier JC; Monroe JG
J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
[TBL] [Abstract][Full Text] [Related]
9. CD40-activated surface IgD-positive lymphocytes constitute the long term IL-4-dependent proliferating B cell pool.
Galibert L; Durand I; Banchereau J; Rousset F
J Immunol; 1994 Jan; 152(1):22-9. PubMed ID: 7504711
[TBL] [Abstract][Full Text] [Related]
10. Human peripheral blood B cell subpopulations: surface IgD+ cells respond to pokeweed mitogen with plasma cell differentiation.
Mudde GC; van Dam D; De Gast GC
Clin Exp Immunol; 1986 Apr; 64(1):150-7. PubMed ID: 3488148
[TBL] [Abstract][Full Text] [Related]
11. The expression of the sIgD isotype in wild-derived mice.
Mami F; Guenet JL; Perret R; Truffa-Bachi P
J Immunol; 1986 Jun; 136(12):4432-7. PubMed ID: 2423594
[TBL] [Abstract][Full Text] [Related]
12. Growth regulation of a human mature B cell line, B104, by anti-IgM and anti-IgD antibodies.
Kim KM; Yoshimura T; Watanabe H; Ishigami T; Nambu M; Hata D; Higaki Y; Sasaki M; Tsutsui T; Mayumi M
J Immunol; 1991 Feb; 146(3):819-25. PubMed ID: 1988498
[TBL] [Abstract][Full Text] [Related]
13. Interactions between lymphocyte membrane molecules. II. Characterization of an interaction between B lymphocyte surface IgD and Fc IgG receptors that differs from the surface IgM-Fc IgG receptor interaction.
Dickler HB; Kubicek MT; Finkelman FD
J Immunol; 1982 Mar; 128(3):1271-7. PubMed ID: 6799572
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of EBV-transformable human B lymphocyte populations.
Chan MA; Stein LD; Dosch HM; Sigal NH
J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
[TBL] [Abstract][Full Text] [Related]
15. Control of B cell proliferation: arrest of B cells in late G1 underlies immunosuppression induced by plasma cell tumors.
Berman JE; Zolla-Pazner S
J Immunol; 1987 May; 138(9):2805-12. PubMed ID: 3494771
[TBL] [Abstract][Full Text] [Related]
16. Development of B lymphocytes in the mouse; studies of the frequency and distribution of surface IgM and IgD in normal and immune-defective CBA/N F1 mice.
Scher I; Berning AK; Kessler S; Finkelman FD
J Immunol; 1980 Oct; 125(4):1686-93. PubMed ID: 6997384
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
18. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.
Thompson CB; Scher I; Schaefer ME; Lindsten T; Finkelman FD; Mond JJ
J Immunol; 1984 Nov; 133(5):2333-42. PubMed ID: 6207226
[TBL] [Abstract][Full Text] [Related]
19. Effects of neonatal anti-delta antibody treatment on the murine immune system. II. Functional capacity of a stable sIgM+sIa+sIgD- B cell population.
Metcalf ES; Mond JJ; Finkelman FD
J Immunol; 1983 Aug; 131(2):601-5. PubMed ID: 6602841
[TBL] [Abstract][Full Text] [Related]
20. Endogenous expression of delta on the surface of WEHI-231. Characterization of its expression and signaling properties.
Haggerty HG; Wechsler RJ; Lentz VM; Monroe JG
J Immunol; 1993 Nov; 151(9):4681-93. PubMed ID: 8409428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
